Connect with us

Abilify (aripiprazole)

Aripiprazole (or ABILIFY®) is mainly prescribed to treat schizophrenia, bipolar disorder, and major depressive disorder.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2002

Dosage Forms: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg

Biological Half-life: 75 hours

Side Effects: Dizziness, nausea, orthostatic hypotension, constipation, headache, movement problems

Routes of Administration: Oral, Sublingual, IM, IV

Pregnancy Category: C (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.